PMID- 29749710 OWN - NLM STAT- MEDLINE DCOM- 20190719 LR - 20240519 IS - 1751-7893 (Electronic) IS - 1751-7885 (Print) IS - 1751-7885 (Linking) VI - 13 IP - 1 DP - 2019 Feb TI - Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis. PG - 3-17 LID - 10.1111/eip.12677 [doi] AB - AIM: Attenuated psychotic symptoms (APSs) have been the primary emphasis in youth at clinical high risk (CHR) for psychosis for assessing symptomology and determining subsequent transition to a psychotic disorder. Previous reviews primarily focused on the efficacy of cognitive behavioural therapy (CBT) on APS; however, a comprehensive assessment of other interventions to date is lacking. Therefore, we conducted a systematic review and meta-analysis of all intervention studies examining APS in CHR youth. METHOD: The authors searched Embase, CINAHL, PsycINFO, Medline and EBM from inception to May 2017. Studies were selected if they included any intervention that reported follow-up APS in youth at CHR. Interventions were evaluated and stratified by time using both pairwise and network meta-analyses (NMAs). Due to the differences in APS scales, effect sizes were calculated as Hedges g and reported as the standardized mean difference (SMD). RESULTS: Forty-one studies met our inclusion criteria. In pairwise meta-analyses, CBT was associated with a trend towards reduction in APS compared to controls at 12-months. In the NMA, integrated psychological therapy, CBT, supportive therapy, family therapy, needs-based interventions, omega-3, risperidone plus CBT and olanzapine were not significantly more effective at reducing APS at 6 and 12 months relative to any other intervention. CONCLUSIONS: CBT demonstrated a slight trend at reducing APS at long-term follow-up compared to controls. No interventions were significantly more effective at reducing APS compared to all other interventions in the NMA. [Correction added on 4 June 2018, after first online publication: Some parts of the Abstract section particularly 'Results' and 'Conclusions' have been corrected.]. CI - (c) 2018 John Wiley & Sons Australia, Ltd. FAU - Devoe, Daniel J AU - Devoe DJ AD - Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada. FAU - Farris, Megan S AU - Farris MS AD - Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada. FAU - Townes, Parker AU - Townes P AD - Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada. FAU - Addington, Jean AU - Addington J AUID- ORCID: 0000-0002-8298-0756 AD - Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada. LA - eng GR - R01 MH105178/MH/NIMH NIH HHS/United States GR - RO1MH105178/MH/NIMH NIH HHS/United States PT - Journal Article PT - Meta-Analysis PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Systematic Review DEP - 20180511 PL - Australia TA - Early Interv Psychiatry JT - Early intervention in psychiatry JID - 101320027 RN - 0 (Antipsychotic Agents) RN - 0 (Fatty Acids, Omega-3) SB - IM MH - Antipsychotic Agents/*therapeutic use MH - Fatty Acids, Omega-3/*therapeutic use MH - Humans MH - *Psychotherapy MH - Psychotic Disorders/diet therapy/drug therapy/*therapy PMC - PMC6230498 MID - NIHMS962862 OTO - NOTNLM OT - clinical high risk OT - meta-analysis OT - schizophrenia OT - systematic review EDAT- 2018/05/12 06:00 MHDA- 2019/07/20 06:00 PMCR- 2020/02/01 CRDT- 2018/05/12 06:00 PHST- 2017/12/04 00:00 [received] PHST- 2018/02/20 00:00 [revised] PHST- 2018/03/13 00:00 [accepted] PHST- 2018/05/12 06:00 [pubmed] PHST- 2019/07/20 06:00 [medline] PHST- 2018/05/12 06:00 [entrez] PHST- 2020/02/01 00:00 [pmc-release] AID - 10.1111/eip.12677 [doi] PST - ppublish SO - Early Interv Psychiatry. 2019 Feb;13(1):3-17. doi: 10.1111/eip.12677. Epub 2018 May 11.